Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Organon & Co. Common Stock
(NY:
OGN
)
7.710
-0.030 (-0.39%)
Official Closing Price
Updated: 5:00 PM EST, Nov 28, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Organon & Co. Common Stock
< Previous
1
2
...
11
12
13
14
15
16
17
18
Next >
Why Organon & Co. Stock Popped Today
↗
January 10, 2024
Organon & Co. (NYSE: OGN) shares traded higher on Wednesday after the company announced the availability of XACIATO 2% by prescription.
Via
Benzinga
Organon’s XACIATO™ (clindamycin phosphate) Vaginal Gel 2% Available Nationwide to Treat Bacterial Vaginosis (BV) in Females Aged 12 and Older
January 10, 2024
From
Organon & Co.
Via
Business Wire
Merck, the Dow's hottest stock, gets set to report Q4 financials
January 08, 2024
Up 5.7% year-to-date, pharmaceuticals - including MRK - are the best performing industry in the entire U.S. equity market, outpacing even biotech stocks.
Via
MarketBeat
Topics
Stocks
Organon affirms 2023 revenue and Adjusted EBITDA guidance and provides 2024 outlook
January 08, 2024
From
Organon & Co.
Via
Business Wire
Analyst Expectations for Organon's Future
↗
November 22, 2023
Via
Benzinga
Organon: Dividend Insights
↗
November 07, 2023
Via
Benzinga
Analyst Ratings for Organon
↗
November 03, 2023
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
↗
December 27, 2023
Via
Benzinga
3 Minutes To Boost Your Earnings: 3 Stocks With Over 3% Dividend Yields In Health Care Sector From Wall Street's Most Accurate Analysts
↗
December 27, 2023
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Via
Benzinga
Organon To Present at the 42nd Annual J.P. Morgan Healthcare Conference
December 21, 2023
From
Organon & Co.
Via
Business Wire
Organon & Lilly Enter Commercialization Agreement in Europe for Two Migraine Medicines
December 18, 2023
From
Organon & Co.
Via
Business Wire
Don't Miss These 3 High-Yielding Dividend Stocks In Health Care Sector From Wall Street's Most Accurate Analysts
↗
December 12, 2023
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Via
Benzinga
Unleashing Growth Potential: Johnson & Johnson Surpasses Expectations with Strong Performance and Increasing Profits
↗
December 05, 2023
Via
Benzinga
Overview Of Value Stocks In The Healthcare Sector
↗
November 27, 2023
Via
Benzinga
Is This Healthcare Stock's 10% Yield a Steal of a Deal or Too Good to Be True?
↗
November 21, 2023
High-yielding stocks may be tantalizing, but they often come with risks.
Via
The Motley Fool
Organon To Present at the Piper Sandler 35th Annual Healthcare Conference
November 21, 2023
From
Organon & Co.
Via
Business Wire
Check Out 3 Health Care Stocks With Over 4% Dividend Yields From Wall Street's Most Accurate Analysts
↗
November 09, 2023
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Via
Benzinga
Samsung Bioepis & Organon Announce FDA Acceptance of Supplemental Biologics License Application (sBLA) for Interchangeability Designation for HADLIMA™ (adalimumab-bwwd), a Biosimilar to Humira®
November 07, 2023
From
Samsung Bioepis
Via
GlobeNewswire
Organon Reports Results for the Third Quarter Ended September 30, 2023
November 02, 2023
From
Organon & Co.
Via
Business Wire
Organon and Sempre Health Announce Collaboration on New Service to Help Eligible Patients Save Money and Stay on Their Medication as Prescribed
November 01, 2023
From
Organon & Co.
Via
Business Wire
A Look Into Healthcare Sector Value Stocks
↗
October 30, 2023
Via
Benzinga
Organon To Report Third Quarter Results and Host Conference Call on November 2, 2023
October 19, 2023
From
Organon & Co.
Via
Business Wire
Lululemon Athletica Races to New High with S&P 500 Entry
October 17, 2023
Lululemon's stock soared 10.31%, its best level since late 2021, upon joining the S&P 500, replacing Activision Blizzard. The change is effective October 18.
Via
MarketBeat
Topics
Stocks
Lululemon Athletica To Join S&P 500 Index; LULU Stock Flashes Buy Signal
↗
October 13, 2023
The yoga retailer will join the index before Wednesday's open.
Via
Investor's Business Daily
Topics
Stocks
10 Health Care Stocks Whale Activity In Today's Session
↗
October 02, 2023
Via
Benzinga
Organon Recognized on Fortune’s 2023 Change the World List for Leadership in Expanding Access to Contraceptive Choice
September 27, 2023
From
Organon & Co.
Via
Business Wire
5 Value Stocks To Watch In The Healthcare Sector
↗
September 25, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 21, 2023
↗
September 21, 2023
Via
Benzinga
First Real-World Observational Study of the JADA® System, a Medical Device to Control Postpartum Hemorrhage (PPH), Published in ACOG’s Obstetrics & Gynecology
September 14, 2023
From
Organon & Co.
Via
Business Wire
3 Pharmaceutical Stocks That Are Too Cheap to Ignore
↗
September 09, 2023
Viatris, GSK, and Organon are all trading at less than 7 times earnings.
Via
The Motley Fool
< Previous
1
2
...
11
12
13
14
15
16
17
18
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today